Axim Biotechnologies, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OID
AXIM Biotechnologies shifts its strategic focus to commercializing FDA-cleared Dry Eye Disease (DED) diagnostic systems, aiming for positive cash flow by the end of 2023.